Eleven Biotherapeutics (NASDAQ: EBIO), a clinical-stage biopharmaceutical company discovering and developing protein therapeutics to treat diseases of the eye, today announced that Abbie Celniker, Ph.D., Eleven’s President and CEO, is scheduled to present at the following healthcare conferences during March 2014.
Help employers find you! Check out all the jobs and post your resume.
